These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 15031600)

  • 1. Pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 in normal mice after systemic exposure to effective and safe antitumor doses.
    Muindi JR; Modzelewski RA; Peng Y; Trump DL; Johnson CS
    Oncology; 2004; 66(1):62-6. PubMed ID: 15031600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of liquid calcitriol formulation in advanced solid tumor patients: comparison with caplet formulation.
    Muindi JR; Potter DM; Peng Y; Johnson CS; Trump DL
    Cancer Chemother Pharmacol; 2005 Nov; 56(5):492-6. PubMed ID: 15918041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of high-dose oral calcitriol: results from a phase 1 trial of calcitriol and paclitaxel.
    Muindi JR; Peng Y; Potter DM; Hershberger PA; Tauch JS; Capozzoli MJ; Egorin MJ; Johnson CS; Trump DL
    Clin Pharmacol Ther; 2002 Dec; 72(6):648-59. PubMed ID: 12496746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronotherapy of high-dose 1,25-dihydroxyvitamin D3 in hemodialysis patients with secondary hyperparathyroidism: a single-dose study.
    Tsuruoka S; Sugimoto K; Ohmori M; Kawaguchi A; Saito T; Fujimura A
    Clin Pharmacol Ther; 1999 Dec; 66(6):609-16. PubMed ID: 10613617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicity and antineoplastic effect of (24R)-1,24-dihydroxyvitamin D3 (PRI-2191).
    Wietrzyk J; Pełczyńska M; Madej J; Dzimira S; Kuśnierczyk H; Kutner A; Szelejewski W; Opolski A
    Steroids; 2004 Sep; 69(10):629-35. PubMed ID: 15465107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
    Zhao RK; Cheng G; Tang J; Song J; Peng WX
    Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D compounds: clinical development as cancer therapy and prevention agents.
    Trump DL; Muindi J; Fakih M; Yu WD; Johnson CS
    Anticancer Res; 2006; 26(4A):2551-6. PubMed ID: 16886663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and tolerability of a single dose of DN-101, a new formulation of calcitriol, in patients with cancer.
    Beer TM; Javle M; Lam GN; Henner WD; Wong A; Trump DL
    Clin Cancer Res; 2005 Nov; 11(21):7794-9. PubMed ID: 16278401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicity and antitumor activity of the vitamin D analogs PRI-1906 and PRI-1907 in combined treatment with cyclophosphamide in a mouse mammary cancer model.
    Wietrzyk J; Nevozhay D; Milczarek M; Filip B; Kutner A
    Cancer Chemother Pharmacol; 2008 Oct; 62(5):787-97. PubMed ID: 18188568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative pharmacokinetics of RAD001 (everolimus) in normal and tumor-bearing rodents.
    O'Reilly T; McSheehy PM; Kawai R; Kretz O; McMahon L; Brueggen J; Bruelisauer A; Gschwind HP; Allegrini PR; Lane HA
    Cancer Chemother Pharmacol; 2010 Mar; 65(4):625-39. PubMed ID: 19784839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of cisplatin antitumor activity using a vitamin D analogue in a murine squamous cell carcinoma model system.
    Light BW; Yu WD; McElwain MC; Russell DM; Trump DL; Johnson CS
    Cancer Res; 1997 Sep; 57(17):3759-64. PubMed ID: 9288784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor effects of two less-calcemic vitamin D analogs (Paricalcitol and QW-1624F2-2) in squamous cell carcinoma cells.
    Alagbala AA; Johnson CS; Trump DL; Posner GH; Foster BA
    Oncology; 2006; 70(6):483-92. PubMed ID: 17237623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of intraprostatic metabolism of 1,25-dihydroxyvitamin D(3) (calcitriol) using a microdialysis technique.
    Konety BR; Somogyi G; Atan A; Muindi J; Chancellor MB; Getzenberg RH
    Urology; 2002 Jun; 59(6):947-52. PubMed ID: 12031392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Phase I trial of calcitriol (1,25-dihydroxycholecalciferol) in patients with advanced malignancy.
    Smith DC; Johnson CS; Freeman CC; Muindi J; Wilson JW; Trump DL
    Clin Cancer Res; 1999 Jun; 5(6):1339-45. PubMed ID: 10389917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of oxaliplatin (NSC 266046) alone and in combination with paclitaxel in cancer patients.
    Liu J; Kraut E; Bender J; Brooks R; Balcerzak S; Grever M; Stanley H; D'Ambrosio S; Gibson-D'Ambrosio R; Chan KK
    Cancer Chemother Pharmacol; 2002 May; 49(5):367-74. PubMed ID: 11976830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A vitamin D analogue (EB1089) inhibits parathyroid hormone-related peptide production and prevents the development of malignancy-associated hypercalcemia in vivo.
    Haq M; Kremer R; Goltzman D; Rabbani SA
    J Clin Invest; 1993 Jun; 91(6):2416-22. PubMed ID: 8514854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcitriol (1,25-dihydroxycholecalciferol) enhances paclitaxel antitumor activity in vitro and in vivo and accelerates paclitaxel-induced apoptosis.
    Hershberger PA; Yu WD; Modzelewski RA; Rueger RM; Johnson CS; Trump DL
    Clin Cancer Res; 2001 Apr; 7(4):1043-51. PubMed ID: 11309356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.